Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
niacinamide/semaglutide Semaglutide: Double-edged Sword with Risks and Benefits persona:wellness-seeker How GLP-1 Medications Are Supply Options:3 Month Supply
How GLP-1 Medications Are Reshaping Consumer Behavior - Holmes Murphy
The first half of the transaction (writing a prescription) is not lawful
persona:wellness-seeker
Supply Options:3 Month Supply
Current NHS eligibility criteria for semaglutide 2.4 mg (Wegovy) for weight management, according to NICE TA875, include: Body Mass Index (BMI) ≥35 kg/m² with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea) For people from certain high-risk ethnic groups (such as South Asian, Chinese, Black African, or African-Caribbean), lower BMI thresholds apply (typically reduced by 2.5 kg/m²) Treatment must be prescribed within specialist weight management services only Treatment is limited to a maximum duration of 2 years Must be used as an adjunct to a reduced-calorie diet and increased physical activity Liraglutide 3 mg (Saxenda) availability varies significantly across NHS regions and is not routinely commissioned in many areas
US$ 24.15
US$ 28.33
US$ 24.60
US$ 26.67
US$ 28.00
US$ 20.41
US$ 21.28
